non-small-cell lung carcinoma

临床试验

计划入组 232 人 · 首次发布于 2013 年 4 月 12 日

终止

NCT02319889

Feasibility Study of SBRT Plus Chemotherapy for Non-Small Cell Lung Carcinoma

计划入组 3 人 · 首次发布于 2014 年 12 月 18 日

Unknown

NCT02283021

Expression and Sequence of Calcium Channels in Non-small Cell Lung Carcinoma (NSCLC)

计划入组 200 人 · 首次发布于 2014 年 11 月 5 日

药物

查看全部 5672 →

Small Molecule

Approved

Osimertinib(Tagrisso)

相关疾病：Metastatic Non-Small Cell Lung Cancer, Non-Small Cell Lung Carcinoma

C₂₈H₃₃N₇O₂ · Rx

Small Molecule

Approved

Gefitinib(Iressa, Gefitinib Mylan)

生产企业：Astrazeneca uk ltd

相关疾病：Metastatic Non-Small Cell Lung Cancer

C₂₂H₂₄ClFN₄O₃ · Rx

Small Molecule

Approved

Vinorelbine

生产企业：Pierre fabre medicament, Actavis totowa llc，另有 6 家

相关疾病：Locally Advanced Non-Small Cell Lung Cancer, Metastatic Breast Cancer，另有 4 项

C₄₅H₅₄N₄O₈ · Rx

机构

查看全部 399 →

A&A SMALL CHANGES HANDYPEOPLE

United States

Lung Therapeutics, Inc.

United States

Sec Lung, LLC

United States

资讯

查看全部 23328 →

2年前

GSK's Dostarlimab Expands Development Portfolio to Target Multiple Advanced Cancers

11个月前

Genprex's Reqorsa Gene Therapy Shows 79% Tumor Reduction in ALK-Positive Lung Cancer Preclinical Study

去年

临床试验

Circulating Tumor Cells in Non-Small Cell Lung Carcinoma

Feasibility Study of SBRT Plus Chemotherapy for Non-Small Cell Lung Carcinoma

Expression and Sequence of Calcium Channels in Non-small Cell Lung Carcinoma (NSCLC)

药物

Osimertinib(Tagrisso)

Gefitinib(Iressa, Gefitinib Mylan)

Vinorelbine

机构

A&A SMALL CHANGES HANDYPEOPLE

Lung Therapeutics, Inc.

Sec Lung, LLC

资讯

GSK's Dostarlimab Expands Development Portfolio to Target Multiple Advanced Cancers

Genprex's Reqorsa Gene Therapy Shows 79% Tumor Reduction in ALK-Positive Lung Cancer Preclinical Study

iTeos Therapeutics Announces Strategic Priorities for 2025, Anticipating Multiple Data Readouts